Literature DB >> 1946308

Effect of L-dopa administration on islet monoamine oxidase activity and glucose-induced insulin release in the mouse.

I Lundquist1, G Panagiotidis, A Stenström.   

Abstract

Previous studies have shown that the amine precursor L-3,4-dihydroxyphenylalanine (L-DOPA) is rapidly converted to its corresponding amine, dopamine, in islet beta-cells. In the present investigation, we studied the effect of acute L-DOPA administration on islet monoamine oxidase (MAO) activity and on glucose-induced insulin secretory response in mice. It was observed that at 2 min after intravenous L-DOPA administration, there was a marked increase (+35%) in islet MAO activity, with serotonin as substrate. At 7 min, MAO activity towards dopamine was enhanced by 32% and that towards serotonin and phenylethylamine (PEA) was decreased by 23 and 25%, respectively. The inhibitor of L-aromatic amino acid decarboxylase, benserazide, abolished L-DOPA-induced changes of MAO activity, suggesting that the formed dopamine, and not L-DOPA itself, was responsible for the observed effects. At 60 min, no effect by L-DOPA administration on islet MAO activity was noticed. L-DOPA (125 or 250 mumol/kg), given together with glucose, induced a decrease in glucose-induced insulin response. L-DOPA (125 mumol/kg), given 7 min before glucose, totally suppressed glucose-induced insulin response. This inhibition was eliminated through pretreatment with benserazide. Enhancement of glucose-stimulated insulin response, after deposition of horseradish peroxidase (HRP) in beta-cell vacuolar system, was suppressed by L-DOPA. We conclude that acute L-DOPA-induced dopamine accumulation in pancreatic islets is accompanied by rapid changes in MAO activity, concomitant with an inhibitory effect on glucose-stimulated insulin response. Increased hydrogen peroxide production, following increased MAO activity, may possibly augment the inhibitory effect of dopamine accumulation on insulin release.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1946308     DOI: 10.1097/00006676-199109000-00004

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  10 in total

Review 1.  Minireview: Dopaminergic regulation of insulin secretion from the pancreatic islet.

Authors:  Alessandro Ustione; David W Piston; Paul E Harris
Journal:  Mol Endocrinol       Date:  2013-06-06

2.  Interaction of the islet nitric oxide system with L-arginine-induced secretion of insulin and glucagon in mice.

Authors:  B Akesson; H Mosén; G Panagiotidis; I Lundquist
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

3.  Islet proteomics reveals genetic variation in dopamine production resulting in altered insulin secretion.

Authors:  Kelly A Mitok; Elyse C Freiberger; Kathryn L Schueler; Mary E Rabaglia; Donald S Stapleton; Nicholas W Kwiecien; Paige A Malec; Alexander S Hebert; Aimee T Broman; Robert T Kennedy; Mark P Keller; Joshua J Coon; Alan D Attie
Journal:  J Biol Chem       Date:  2018-03-01       Impact factor: 5.157

4.  Influence of nitric oxide modulators on cholinergically stimulated hormone release from mouse islets.

Authors:  B Aring;kesson; I Lundquist
Journal:  J Physiol       Date:  1999-03-01       Impact factor: 5.182

5.  Nitric oxide and hydroperoxide affect islet hormone release and Ca(2+) efflux.

Authors:  B Akesson; I Lundquist
Journal:  Endocrine       Date:  1999-08       Impact factor: 3.633

6.  Dopamine synthesis and D3 receptor activation in pancreatic β-cells regulates insulin secretion and intracellular [Ca(2+)] oscillations.

Authors:  Alessandro Ustione; David W Piston
Journal:  Mol Endocrinol       Date:  2012-08-23

7.  Influence of nitric oxide synthase inhibition, nitric oxide and hydroperoxide on insulin release induced by various secretagogues.

Authors:  G Panagiotidis; B Akesson; E L Rydell; I Lundquist
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

Review 8.  Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity.

Authors:  Suleman Chaudhry; Marilia Bernardes; Paul E Harris; Antonella Maffei
Journal:  Minerva Endocrinol       Date:  2015-10-27       Impact factor: 2.184

9.  Aromatic-L-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a beta-cell autoantigen.

Authors:  F Rorsman; E S Husebye; O Winqvist; E Björk; F A Karlsson; O Kämpe
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

10.  Metabolic changes induced by oral glucose tests in horses and their diagnostic use.

Authors:  Julien Delarocque; Florian Frers; Karsten Feige; Korinna Huber; Klaus Jung; Tobias Warnken
Journal:  J Vet Intern Med       Date:  2020-12-05       Impact factor: 3.175

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.